nodes	percent_of_prediction	percent_of_DWPC	metapath
Amprenavir—CYP2B6—Thiotepa—urinary bladder cancer	0.12	0.156	CbGbCtD
Amprenavir—ABCC1—Epirubicin—urinary bladder cancer	0.0884	0.115	CbGbCtD
Amprenavir—ABCB1—Mitomycin—urinary bladder cancer	0.0809	0.106	CbGbCtD
Amprenavir—ABCC1—Etoposide—urinary bladder cancer	0.0689	0.0899	CbGbCtD
Amprenavir—ABCC1—Doxorubicin—urinary bladder cancer	0.047	0.0613	CbGbCtD
Amprenavir—ABCC1—Methotrexate—urinary bladder cancer	0.0455	0.0594	CbGbCtD
Amprenavir—CYP3A4—Thiotepa—urinary bladder cancer	0.0367	0.0479	CbGbCtD
Amprenavir—CYP2B6—Cisplatin—urinary bladder cancer	0.033	0.0431	CbGbCtD
Amprenavir—CYP2C8—Fluorouracil—urinary bladder cancer	0.0294	0.0384	CbGbCtD
Amprenavir—CYP3A5—Etoposide—urinary bladder cancer	0.0255	0.0333	CbGbCtD
Amprenavir—CYP2C8—Etoposide—urinary bladder cancer	0.0246	0.0321	CbGbCtD
Amprenavir—ABCB1—Gemcitabine—urinary bladder cancer	0.0233	0.0304	CbGbCtD
Amprenavir—CYP2B6—Doxorubicin—urinary bladder cancer	0.0221	0.0289	CbGbCtD
Amprenavir—CYP2C9—Fluorouracil—urinary bladder cancer	0.0205	0.0268	CbGbCtD
Amprenavir—CYP2C9—Cisplatin—urinary bladder cancer	0.0174	0.0228	CbGbCtD
Amprenavir—ABCB1—Cisplatin—urinary bladder cancer	0.0169	0.0221	CbGbCtD
Amprenavir—ABCB1—Etoposide—urinary bladder cancer	0.0166	0.0217	CbGbCtD
Amprenavir—ABCB1—Doxorubicin—urinary bladder cancer	0.0113	0.0148	CbGbCtD
Amprenavir—ABCB1—Methotrexate—urinary bladder cancer	0.011	0.0143	CbGbCtD
Amprenavir—CYP2D6—Doxorubicin—urinary bladder cancer	0.0107	0.0139	CbGbCtD
Amprenavir—CYP3A4—Etoposide—urinary bladder cancer	0.00996	0.013	CbGbCtD
Amprenavir—CYP3A4—Doxorubicin—urinary bladder cancer	0.00679	0.00887	CbGbCtD
Amprenavir—CYP2C19—urine—urinary bladder cancer	0.00353	0.134	CbGeAlD
Amprenavir—CYP2C9—urine—urinary bladder cancer	0.00274	0.104	CbGeAlD
Amprenavir—CYP3A4—urine—urinary bladder cancer	0.00209	0.0793	CbGeAlD
Amprenavir—CYP2D6—urine—urinary bladder cancer	0.00205	0.0781	CbGeAlD
Amprenavir—ABCC1—prostate gland—urinary bladder cancer	0.0013	0.0494	CbGeAlD
Amprenavir—ABCC1—seminal vesicle—urinary bladder cancer	0.0011	0.0418	CbGeAlD
Amprenavir—CYP3A5—prostate gland—urinary bladder cancer	0.000999	0.0379	CbGeAlD
Amprenavir—ABCC1—urethra—urinary bladder cancer	0.00087	0.0331	CbGeAlD
Amprenavir—Aspartate aminotransferase increased—Thiotepa—urinary bladder cancer	0.000783	0.00691	CcSEcCtD
Amprenavir—Rash—Valrubicin—urinary bladder cancer	0.000778	0.00687	CcSEcCtD
Amprenavir—Dermatitis—Valrubicin—urinary bladder cancer	0.000777	0.00686	CcSEcCtD
Amprenavir—Headache—Valrubicin—urinary bladder cancer	0.000773	0.00682	CcSEcCtD
Amprenavir—Alanine aminotransferase increased—Thiotepa—urinary bladder cancer	0.000767	0.00677	CcSEcCtD
Amprenavir—CYP2C8—renal system—urinary bladder cancer	0.000754	0.0287	CbGeAlD
Amprenavir—Decreased appetite—Mitomycin—urinary bladder cancer	0.000739	0.00652	CcSEcCtD
Amprenavir—Transaminases increased—Doxorubicin—urinary bladder cancer	0.000734	0.00648	CcSEcCtD
Amprenavir—Nausea—Valrubicin—urinary bladder cancer	0.000733	0.00647	CcSEcCtD
Amprenavir—Fatigue—Mitomycin—urinary bladder cancer	0.000733	0.00647	CcSEcCtD
Amprenavir—CYP3A5—renal system—urinary bladder cancer	0.000681	0.0259	CbGeAlD
Amprenavir—Hyperglycaemia—Thiotepa—urinary bladder cancer	0.000678	0.00599	CcSEcCtD
Amprenavir—CYP2B6—renal system—urinary bladder cancer	0.000676	0.0257	CbGeAlD
Amprenavir—Liver function test abnormal—Gemcitabine—urinary bladder cancer	0.000676	0.00596	CcSEcCtD
Amprenavir—Aspartate aminotransferase increased—Gemcitabine—urinary bladder cancer	0.000659	0.00582	CcSEcCtD
Amprenavir—Alanine aminotransferase increased—Gemcitabine—urinary bladder cancer	0.000645	0.0057	CcSEcCtD
Amprenavir—ABCC1—vagina—urinary bladder cancer	0.000641	0.0244	CbGeAlD
Amprenavir—Hepatobiliary disease—Thiotepa—urinary bladder cancer	0.000634	0.0056	CcSEcCtD
Amprenavir—CYP2C19—vagina—urinary bladder cancer	0.000626	0.0238	CbGeAlD
Amprenavir—Aspartate aminotransferase increased—Cisplatin—urinary bladder cancer	0.000614	0.00542	CcSEcCtD
Amprenavir—Asthenia—Mitomycin—urinary bladder cancer	0.00061	0.00538	CcSEcCtD
Amprenavir—CYP2C8—female reproductive system—urinary bladder cancer	0.000604	0.023	CbGeAlD
Amprenavir—Neutropenia—Gemcitabine—urinary bladder cancer	0.000591	0.00522	CcSEcCtD
Amprenavir—Connective tissue disorder—Thiotepa—urinary bladder cancer	0.000591	0.00522	CcSEcCtD
Amprenavir—Diarrhoea—Mitomycin—urinary bladder cancer	0.000582	0.00513	CcSEcCtD
Amprenavir—Hyperglycaemia—Gemcitabine—urinary bladder cancer	0.000571	0.00503	CcSEcCtD
Amprenavir—Hyperbilirubinaemia—Methotrexate—urinary bladder cancer	0.000567	0.005	CcSEcCtD
Amprenavir—Abdominal discomfort—Cisplatin—urinary bladder cancer	0.000565	0.00499	CcSEcCtD
Amprenavir—Stevens-Johnson syndrome—Gemcitabine—urinary bladder cancer	0.000559	0.00493	CcSEcCtD
Amprenavir—Cardiac disorder—Thiotepa—urinary bladder cancer	0.000559	0.00493	CcSEcCtD
Amprenavir—Acute coronary syndrome—Gemcitabine—urinary bladder cancer	0.000556	0.00491	CcSEcCtD
Amprenavir—Myocardial infarction—Gemcitabine—urinary bladder cancer	0.000553	0.00488	CcSEcCtD
Amprenavir—Alanine aminotransferase increased—Etoposide—urinary bladder cancer	0.000551	0.00486	CcSEcCtD
Amprenavir—Acute coronary syndrome—Fluorouracil—urinary bladder cancer	0.000547	0.00482	CcSEcCtD
Amprenavir—CYP2C8—vagina—urinary bladder cancer	0.000546	0.0208	CbGeAlD
Amprenavir—Myocardial infarction—Fluorouracil—urinary bladder cancer	0.000543	0.0048	CcSEcCtD
Amprenavir—CYP2B6—female reproductive system—urinary bladder cancer	0.000542	0.0206	CbGeAlD
Amprenavir—Vomiting—Mitomycin—urinary bladder cancer	0.000541	0.00477	CcSEcCtD
Amprenavir—CYP2C9—female reproductive system—urinary bladder cancer	0.000536	0.0204	CbGeAlD
Amprenavir—Rash—Mitomycin—urinary bladder cancer	0.000536	0.00473	CcSEcCtD
Amprenavir—Dermatitis—Mitomycin—urinary bladder cancer	0.000536	0.00473	CcSEcCtD
Amprenavir—Hepatobiliary disease—Gemcitabine—urinary bladder cancer	0.000533	0.00471	CcSEcCtD
Amprenavir—Headache—Mitomycin—urinary bladder cancer	0.000533	0.0047	CcSEcCtD
Amprenavir—Inflammation—Methotrexate—urinary bladder cancer	0.000532	0.00469	CcSEcCtD
Amprenavir—Hyperbilirubinaemia—Epirubicin—urinary bladder cancer	0.000531	0.00468	CcSEcCtD
Amprenavir—ABCB1—prostate gland—urinary bladder cancer	0.00053	0.0202	CbGeAlD
Amprenavir—Mental disorder—Thiotepa—urinary bladder cancer	0.000527	0.00465	CcSEcCtD
Amprenavir—Malnutrition—Thiotepa—urinary bladder cancer	0.000524	0.00462	CcSEcCtD
Amprenavir—Acute coronary syndrome—Cisplatin—urinary bladder cancer	0.000518	0.00457	CcSEcCtD
Amprenavir—Myocardial infarction—Cisplatin—urinary bladder cancer	0.000515	0.00455	CcSEcCtD
Amprenavir—CYP3A4—renal system—urinary bladder cancer	0.000511	0.0194	CbGeAlD
Amprenavir—Neutropenia—Etoposide—urinary bladder cancer	0.000505	0.00446	CcSEcCtD
Amprenavir—Nausea—Mitomycin—urinary bladder cancer	0.000505	0.00446	CcSEcCtD
Amprenavir—CYP2D6—renal system—urinary bladder cancer	0.000503	0.0191	CbGeAlD
Amprenavir—Connective tissue disorder—Gemcitabine—urinary bladder cancer	0.000497	0.00439	CcSEcCtD
Amprenavir—Inflammation—Epirubicin—urinary bladder cancer	0.000497	0.00439	CcSEcCtD
Amprenavir—Hepatobiliary disease—Cisplatin—urinary bladder cancer	0.000497	0.00439	CcSEcCtD
Amprenavir—CYP3A5—vagina—urinary bladder cancer	0.000493	0.0187	CbGeAlD
Amprenavir—Hyperbilirubinaemia—Doxorubicin—urinary bladder cancer	0.000491	0.00433	CcSEcCtD
Amprenavir—CYP2B6—vagina—urinary bladder cancer	0.00049	0.0186	CbGeAlD
Amprenavir—Erythema multiforme—Gemcitabine—urinary bladder cancer	0.000479	0.00422	CcSEcCtD
Amprenavir—Stevens-Johnson syndrome—Etoposide—urinary bladder cancer	0.000477	0.00421	CcSEcCtD
Amprenavir—Acute coronary syndrome—Etoposide—urinary bladder cancer	0.000475	0.00419	CcSEcCtD
Amprenavir—Myocardial infarction—Etoposide—urinary bladder cancer	0.000472	0.00417	CcSEcCtD
Amprenavir—Cardiac disorder—Gemcitabine—urinary bladder cancer	0.00047	0.00415	CcSEcCtD
Amprenavir—Connective tissue disorder—Cisplatin—urinary bladder cancer	0.000464	0.00409	CcSEcCtD
Amprenavir—Inflammation—Doxorubicin—urinary bladder cancer	0.00046	0.00406	CcSEcCtD
Amprenavir—Hepatobiliary disease—Etoposide—urinary bladder cancer	0.000455	0.00402	CcSEcCtD
Amprenavir—ABCB1—seminal vesicle—urinary bladder cancer	0.000449	0.0171	CbGeAlD
Amprenavir—Myalgia—Thiotepa—urinary bladder cancer	0.000446	0.00394	CcSEcCtD
Amprenavir—Unspecified disorder of skin and subcutaneous tissue—Thiotepa—urinary bladder cancer	0.000443	0.00391	CcSEcCtD
Amprenavir—Cardiac disorder—Cisplatin—urinary bladder cancer	0.000438	0.00386	CcSEcCtD
Amprenavir—Diabetes mellitus—Methotrexate—urinary bladder cancer	0.00043	0.0038	CcSEcCtD
Amprenavir—Nervous system disorder—Thiotepa—urinary bladder cancer	0.000419	0.0037	CcSEcCtD
Amprenavir—Skin disorder—Thiotepa—urinary bladder cancer	0.000415	0.00367	CcSEcCtD
Amprenavir—ABCC1—lymph node—urinary bladder cancer	0.000415	0.0158	CbGeAlD
Amprenavir—Malnutrition—Cisplatin—urinary bladder cancer	0.000411	0.00362	CcSEcCtD
Amprenavir—CYP3A4—female reproductive system—urinary bladder cancer	0.000409	0.0155	CbGeAlD
Amprenavir—Erythema multiforme—Etoposide—urinary bladder cancer	0.000409	0.00361	CcSEcCtD
Amprenavir—Anorexia—Thiotepa—urinary bladder cancer	0.000408	0.0036	CcSEcCtD
Amprenavir—Flatulence—Cisplatin—urinary bladder cancer	0.000405	0.00357	CcSEcCtD
Amprenavir—Diabetes mellitus—Epirubicin—urinary bladder cancer	0.000403	0.00355	CcSEcCtD
Amprenavir—CYP2D6—female reproductive system—urinary bladder cancer	0.000403	0.0153	CbGeAlD
Amprenavir—Cardiac disorder—Etoposide—urinary bladder cancer	0.000401	0.00354	CcSEcCtD
Amprenavir—ABCB1—epithelium—urinary bladder cancer	0.00039	0.0148	CbGeAlD
Amprenavir—Musculoskeletal discomfort—Thiotepa—urinary bladder cancer	0.00039	0.00344	CcSEcCtD
Amprenavir—Tremor—Cisplatin—urinary bladder cancer	0.000385	0.0034	CcSEcCtD
Amprenavir—Paraesthesia—Thiotepa—urinary bladder cancer	0.000384	0.00339	CcSEcCtD
Amprenavir—Myalgia—Gemcitabine—urinary bladder cancer	0.000375	0.00331	CcSEcCtD
Amprenavir—Diabetes mellitus—Doxorubicin—urinary bladder cancer	0.000373	0.00329	CcSEcCtD
Amprenavir—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—urinary bladder cancer	0.000373	0.00329	CcSEcCtD
Amprenavir—Decreased appetite—Thiotepa—urinary bladder cancer	0.000372	0.00328	CcSEcCtD
Amprenavir—Discomfort—Gemcitabine—urinary bladder cancer	0.000371	0.00327	CcSEcCtD
Amprenavir—Gastrointestinal disorder—Thiotepa—urinary bladder cancer	0.000369	0.00326	CcSEcCtD
Amprenavir—Myalgia—Fluorouracil—urinary bladder cancer	0.000369	0.00326	CcSEcCtD
Amprenavir—Fatigue—Thiotepa—urinary bladder cancer	0.000369	0.00325	CcSEcCtD
Amprenavir—Discomfort—Fluorouracil—urinary bladder cancer	0.000364	0.00322	CcSEcCtD
Amprenavir—ABCB1—renal system—urinary bladder cancer	0.000362	0.0137	CbGeAlD
Amprenavir—ABCB1—urethra—urinary bladder cancer	0.000355	0.0135	CbGeAlD
Amprenavir—Nervous system disorder—Gemcitabine—urinary bladder cancer	0.000353	0.00311	CcSEcCtD
Amprenavir—Myalgia—Cisplatin—urinary bladder cancer	0.00035	0.00309	CcSEcCtD
Amprenavir—Gastrointestinal pain—Thiotepa—urinary bladder cancer	0.00035	0.00309	CcSEcCtD
Amprenavir—Skin disorder—Gemcitabine—urinary bladder cancer	0.000349	0.00308	CcSEcCtD
Amprenavir—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—urinary bladder cancer	0.000347	0.00306	CcSEcCtD
Amprenavir—Nervous system disorder—Fluorouracil—urinary bladder cancer	0.000347	0.00306	CcSEcCtD
Amprenavir—Liver function test abnormal—Methotrexate—urinary bladder cancer	0.000346	0.00305	CcSEcCtD
Amprenavir—Discomfort—Cisplatin—urinary bladder cancer	0.000346	0.00305	CcSEcCtD
Amprenavir—Anorexia—Gemcitabine—urinary bladder cancer	0.000343	0.00303	CcSEcCtD
Amprenavir—Abdominal pain—Thiotepa—urinary bladder cancer	0.000338	0.00298	CcSEcCtD
Amprenavir—Anorexia—Fluorouracil—urinary bladder cancer	0.000337	0.00297	CcSEcCtD
Amprenavir—Nervous system disorder—Cisplatin—urinary bladder cancer	0.000329	0.0029	CcSEcCtD
Amprenavir—Musculoskeletal discomfort—Gemcitabine—urinary bladder cancer	0.000328	0.00289	CcSEcCtD
Amprenavir—Skin disorder—Cisplatin—urinary bladder cancer	0.000326	0.00287	CcSEcCtD
Amprenavir—Liver function test abnormal—Epirubicin—urinary bladder cancer	0.000323	0.00285	CcSEcCtD
Amprenavir—Paraesthesia—Gemcitabine—urinary bladder cancer	0.000323	0.00285	CcSEcCtD
Amprenavir—Musculoskeletal discomfort—Fluorouracil—urinary bladder cancer	0.000322	0.00284	CcSEcCtD
Amprenavir—Anorexia—Cisplatin—urinary bladder cancer	0.00032	0.00282	CcSEcCtD
Amprenavir—Unspecified disorder of skin and subcutaneous tissue—Etoposide—urinary bladder cancer	0.000318	0.00281	CcSEcCtD
Amprenavir—Paraesthesia—Fluorouracil—urinary bladder cancer	0.000318	0.0028	CcSEcCtD
Amprenavir—Discomfort—Etoposide—urinary bladder cancer	0.000317	0.00279	CcSEcCtD
Amprenavir—Aspartate aminotransferase increased—Epirubicin—urinary bladder cancer	0.000315	0.00278	CcSEcCtD
Amprenavir—Decreased appetite—Gemcitabine—urinary bladder cancer	0.000313	0.00276	CcSEcCtD
Amprenavir—Gastrointestinal disorder—Gemcitabine—urinary bladder cancer	0.000311	0.00274	CcSEcCtD
Amprenavir—Abdominal discomfort—Methotrexate—urinary bladder cancer	0.00031	0.00274	CcSEcCtD
Amprenavir—Fatigue—Gemcitabine—urinary bladder cancer	0.00031	0.00274	CcSEcCtD
Amprenavir—Alanine aminotransferase increased—Epirubicin—urinary bladder cancer	0.000309	0.00273	CcSEcCtD
Amprenavir—Decreased appetite—Fluorouracil—urinary bladder cancer	0.000307	0.00271	CcSEcCtD
Amprenavir—Asthenia—Thiotepa—urinary bladder cancer	0.000307	0.00271	CcSEcCtD
Amprenavir—Musculoskeletal discomfort—Cisplatin—urinary bladder cancer	0.000305	0.0027	CcSEcCtD
Amprenavir—Gastrointestinal disorder—Fluorouracil—urinary bladder cancer	0.000305	0.00269	CcSEcCtD
Amprenavir—Neutropenia—Methotrexate—urinary bladder cancer	0.000302	0.00267	CcSEcCtD
Amprenavir—Pruritus—Thiotepa—urinary bladder cancer	0.000302	0.00267	CcSEcCtD
Amprenavir—Paraesthesia—Cisplatin—urinary bladder cancer	0.000301	0.00266	CcSEcCtD
Amprenavir—Liver function test abnormal—Doxorubicin—urinary bladder cancer	0.000299	0.00264	CcSEcCtD
Amprenavir—Skin disorder—Etoposide—urinary bladder cancer	0.000298	0.00263	CcSEcCtD
Amprenavir—Anorexia—Etoposide—urinary bladder cancer	0.000293	0.00258	CcSEcCtD
Amprenavir—Diarrhoea—Thiotepa—urinary bladder cancer	0.000293	0.00258	CcSEcCtD
Amprenavir—Aspartate aminotransferase increased—Doxorubicin—urinary bladder cancer	0.000292	0.00258	CcSEcCtD
Amprenavir—Decreased appetite—Cisplatin—urinary bladder cancer	0.000291	0.00257	CcSEcCtD
Amprenavir—ABCB1—female reproductive system—urinary bladder cancer	0.00029	0.011	CbGeAlD
Amprenavir—Gastrointestinal disorder—Cisplatin—urinary bladder cancer	0.000289	0.00255	CcSEcCtD
Amprenavir—Depression—Methotrexate—urinary bladder cancer	0.000288	0.00254	CcSEcCtD
Amprenavir—Stevens-Johnson syndrome—Methotrexate—urinary bladder cancer	0.000286	0.00252	CcSEcCtD
Amprenavir—Alanine aminotransferase increased—Doxorubicin—urinary bladder cancer	0.000286	0.00252	CcSEcCtD
Amprenavir—Neutropenia—Epirubicin—urinary bladder cancer	0.000283	0.0025	CcSEcCtD
Amprenavir—Paraesthesia—Etoposide—urinary bladder cancer	0.000276	0.00243	CcSEcCtD
Amprenavir—Hyperglycaemia—Epirubicin—urinary bladder cancer	0.000273	0.00241	CcSEcCtD
Amprenavir—Hepatobiliary disease—Methotrexate—urinary bladder cancer	0.000273	0.00241	CcSEcCtD
Amprenavir—Vomiting—Thiotepa—urinary bladder cancer	0.000272	0.0024	CcSEcCtD
Amprenavir—Rash—Thiotepa—urinary bladder cancer	0.00027	0.00238	CcSEcCtD
Amprenavir—Dermatitis—Thiotepa—urinary bladder cancer	0.000269	0.00238	CcSEcCtD
Amprenavir—Headache—Thiotepa—urinary bladder cancer	0.000268	0.00236	CcSEcCtD
Amprenavir—Stevens-Johnson syndrome—Epirubicin—urinary bladder cancer	0.000268	0.00236	CcSEcCtD
Amprenavir—Decreased appetite—Etoposide—urinary bladder cancer	0.000267	0.00236	CcSEcCtD
Amprenavir—Gastrointestinal disorder—Etoposide—urinary bladder cancer	0.000265	0.00234	CcSEcCtD
Amprenavir—Fatigue—Etoposide—urinary bladder cancer	0.000265	0.00234	CcSEcCtD
Amprenavir—Neutropenia—Doxorubicin—urinary bladder cancer	0.000262	0.00231	CcSEcCtD
Amprenavir—ABCB1—vagina—urinary bladder cancer	0.000262	0.00995	CbGeAlD
Amprenavir—Asthenia—Gemcitabine—urinary bladder cancer	0.000258	0.00228	CcSEcCtD
Amprenavir—Hepatobiliary disease—Epirubicin—urinary bladder cancer	0.000255	0.00225	CcSEcCtD
Amprenavir—Pruritus—Gemcitabine—urinary bladder cancer	0.000254	0.00225	CcSEcCtD
Amprenavir—Nausea—Thiotepa—urinary bladder cancer	0.000254	0.00224	CcSEcCtD
Amprenavir—Hyperglycaemia—Doxorubicin—urinary bladder cancer	0.000253	0.00223	CcSEcCtD
Amprenavir—Gastrointestinal pain—Etoposide—urinary bladder cancer	0.000251	0.00222	CcSEcCtD
Amprenavir—Pruritus—Fluorouracil—urinary bladder cancer	0.00025	0.00221	CcSEcCtD
Amprenavir—Stevens-Johnson syndrome—Doxorubicin—urinary bladder cancer	0.000248	0.00219	CcSEcCtD
Amprenavir—Diarrhoea—Gemcitabine—urinary bladder cancer	0.000246	0.00217	CcSEcCtD
Amprenavir—Erythema multiforme—Methotrexate—urinary bladder cancer	0.000245	0.00216	CcSEcCtD
Amprenavir—Abdominal pain—Etoposide—urinary bladder cancer	0.000243	0.00214	CcSEcCtD
Amprenavir—Diarrhoea—Fluorouracil—urinary bladder cancer	0.000242	0.00214	CcSEcCtD
Amprenavir—Asthenia—Cisplatin—urinary bladder cancer	0.000241	0.00212	CcSEcCtD
Amprenavir—Cardiac disorder—Methotrexate—urinary bladder cancer	0.00024	0.00212	CcSEcCtD
Amprenavir—Connective tissue disorder—Epirubicin—urinary bladder cancer	0.000238	0.0021	CcSEcCtD
Amprenavir—Hepatobiliary disease—Doxorubicin—urinary bladder cancer	0.000236	0.00208	CcSEcCtD
Amprenavir—Diarrhoea—Cisplatin—urinary bladder cancer	0.000229	0.00202	CcSEcCtD
Amprenavir—Erythema multiforme—Epirubicin—urinary bladder cancer	0.000229	0.00202	CcSEcCtD
Amprenavir—Vomiting—Gemcitabine—urinary bladder cancer	0.000229	0.00202	CcSEcCtD
Amprenavir—Mental disorder—Methotrexate—urinary bladder cancer	0.000227	0.002	CcSEcCtD
Amprenavir—Rash—Gemcitabine—urinary bladder cancer	0.000227	0.002	CcSEcCtD
Amprenavir—Dermatitis—Gemcitabine—urinary bladder cancer	0.000227	0.002	CcSEcCtD
Amprenavir—Malnutrition—Methotrexate—urinary bladder cancer	0.000225	0.00199	CcSEcCtD
Amprenavir—Headache—Gemcitabine—urinary bladder cancer	0.000225	0.00199	CcSEcCtD
Amprenavir—Cardiac disorder—Epirubicin—urinary bladder cancer	0.000225	0.00198	CcSEcCtD
Amprenavir—Vomiting—Fluorouracil—urinary bladder cancer	0.000225	0.00198	CcSEcCtD
Amprenavir—Rash—Fluorouracil—urinary bladder cancer	0.000223	0.00197	CcSEcCtD
Amprenavir—Dermatitis—Fluorouracil—urinary bladder cancer	0.000223	0.00197	CcSEcCtD
Amprenavir—Headache—Fluorouracil—urinary bladder cancer	0.000222	0.00196	CcSEcCtD
Amprenavir—Asthenia—Etoposide—urinary bladder cancer	0.00022	0.00194	CcSEcCtD
Amprenavir—Connective tissue disorder—Doxorubicin—urinary bladder cancer	0.00022	0.00194	CcSEcCtD
Amprenavir—Pruritus—Etoposide—urinary bladder cancer	0.000217	0.00192	CcSEcCtD
Amprenavir—Nausea—Gemcitabine—urinary bladder cancer	0.000214	0.00189	CcSEcCtD
Amprenavir—Vomiting—Cisplatin—urinary bladder cancer	0.000213	0.00188	CcSEcCtD
Amprenavir—Mental disorder—Epirubicin—urinary bladder cancer	0.000212	0.00187	CcSEcCtD
Amprenavir—Erythema multiforme—Doxorubicin—urinary bladder cancer	0.000212	0.00187	CcSEcCtD
Amprenavir—Rash—Cisplatin—urinary bladder cancer	0.000211	0.00187	CcSEcCtD
Amprenavir—Dermatitis—Cisplatin—urinary bladder cancer	0.000211	0.00186	CcSEcCtD
Amprenavir—Malnutrition—Epirubicin—urinary bladder cancer	0.000211	0.00186	CcSEcCtD
Amprenavir—Diarrhoea—Etoposide—urinary bladder cancer	0.00021	0.00185	CcSEcCtD
Amprenavir—Nausea—Fluorouracil—urinary bladder cancer	0.00021	0.00185	CcSEcCtD
Amprenavir—Cardiac disorder—Doxorubicin—urinary bladder cancer	0.000208	0.00184	CcSEcCtD
Amprenavir—Flatulence—Epirubicin—urinary bladder cancer	0.000208	0.00183	CcSEcCtD
Amprenavir—Nausea—Cisplatin—urinary bladder cancer	0.000199	0.00176	CcSEcCtD
Amprenavir—Mental disorder—Doxorubicin—urinary bladder cancer	0.000196	0.00173	CcSEcCtD
Amprenavir—Vomiting—Etoposide—urinary bladder cancer	0.000195	0.00172	CcSEcCtD
Amprenavir—Malnutrition—Doxorubicin—urinary bladder cancer	0.000195	0.00172	CcSEcCtD
Amprenavir—Rash—Etoposide—urinary bladder cancer	0.000194	0.00171	CcSEcCtD
Amprenavir—Dermatitis—Etoposide—urinary bladder cancer	0.000193	0.00171	CcSEcCtD
Amprenavir—Headache—Etoposide—urinary bladder cancer	0.000192	0.0017	CcSEcCtD
Amprenavir—Flatulence—Doxorubicin—urinary bladder cancer	0.000192	0.0017	CcSEcCtD
Amprenavir—Myalgia—Methotrexate—urinary bladder cancer	0.000192	0.00169	CcSEcCtD
Amprenavir—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—urinary bladder cancer	0.000191	0.00168	CcSEcCtD
Amprenavir—Discomfort—Methotrexate—urinary bladder cancer	0.00019	0.00167	CcSEcCtD
Amprenavir—Nausea—Etoposide—urinary bladder cancer	0.000182	0.00161	CcSEcCtD
Amprenavir—Nervous system disorder—Methotrexate—urinary bladder cancer	0.00018	0.00159	CcSEcCtD
Amprenavir—Myalgia—Epirubicin—urinary bladder cancer	0.00018	0.00158	CcSEcCtD
Amprenavir—Skin disorder—Methotrexate—urinary bladder cancer	0.000179	0.00158	CcSEcCtD
Amprenavir—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—urinary bladder cancer	0.000178	0.00157	CcSEcCtD
Amprenavir—Discomfort—Epirubicin—urinary bladder cancer	0.000177	0.00157	CcSEcCtD
Amprenavir—Anorexia—Methotrexate—urinary bladder cancer	0.000175	0.00155	CcSEcCtD
Amprenavir—ABCB1—lymph node—urinary bladder cancer	0.000169	0.00644	CbGeAlD
Amprenavir—Nervous system disorder—Epirubicin—urinary bladder cancer	0.000169	0.00149	CcSEcCtD
Amprenavir—Musculoskeletal discomfort—Methotrexate—urinary bladder cancer	0.000168	0.00148	CcSEcCtD
Amprenavir—Skin disorder—Epirubicin—urinary bladder cancer	0.000167	0.00148	CcSEcCtD
Amprenavir—Myalgia—Doxorubicin—urinary bladder cancer	0.000166	0.00147	CcSEcCtD
Amprenavir—Paraesthesia—Methotrexate—urinary bladder cancer	0.000165	0.00146	CcSEcCtD
Amprenavir—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—urinary bladder cancer	0.000165	0.00146	CcSEcCtD
Amprenavir—Discomfort—Doxorubicin—urinary bladder cancer	0.000164	0.00145	CcSEcCtD
Amprenavir—Anorexia—Epirubicin—urinary bladder cancer	0.000164	0.00145	CcSEcCtD
Amprenavir—Decreased appetite—Methotrexate—urinary bladder cancer	0.00016	0.00141	CcSEcCtD
Amprenavir—Gastrointestinal disorder—Methotrexate—urinary bladder cancer	0.000159	0.0014	CcSEcCtD
Amprenavir—Fatigue—Methotrexate—urinary bladder cancer	0.000159	0.0014	CcSEcCtD
Amprenavir—Musculoskeletal discomfort—Epirubicin—urinary bladder cancer	0.000157	0.00138	CcSEcCtD
Amprenavir—Nervous system disorder—Doxorubicin—urinary bladder cancer	0.000156	0.00138	CcSEcCtD
Amprenavir—Skin disorder—Doxorubicin—urinary bladder cancer	0.000155	0.00137	CcSEcCtD
Amprenavir—Paraesthesia—Epirubicin—urinary bladder cancer	0.000155	0.00136	CcSEcCtD
Amprenavir—Anorexia—Doxorubicin—urinary bladder cancer	0.000152	0.00134	CcSEcCtD
Amprenavir—Gastrointestinal pain—Methotrexate—urinary bladder cancer	0.00015	0.00133	CcSEcCtD
Amprenavir—Decreased appetite—Epirubicin—urinary bladder cancer	0.00015	0.00132	CcSEcCtD
Amprenavir—Gastrointestinal disorder—Epirubicin—urinary bladder cancer	0.000149	0.00131	CcSEcCtD
Amprenavir—Fatigue—Epirubicin—urinary bladder cancer	0.000148	0.00131	CcSEcCtD
Amprenavir—Abdominal pain—Methotrexate—urinary bladder cancer	0.000145	0.00128	CcSEcCtD
Amprenavir—Musculoskeletal discomfort—Doxorubicin—urinary bladder cancer	0.000145	0.00128	CcSEcCtD
Amprenavir—Paraesthesia—Doxorubicin—urinary bladder cancer	0.000143	0.00126	CcSEcCtD
Amprenavir—Gastrointestinal pain—Epirubicin—urinary bladder cancer	0.000141	0.00124	CcSEcCtD
Amprenavir—Decreased appetite—Doxorubicin—urinary bladder cancer	0.000138	0.00122	CcSEcCtD
Amprenavir—Gastrointestinal disorder—Doxorubicin—urinary bladder cancer	0.000138	0.00121	CcSEcCtD
Amprenavir—Fatigue—Doxorubicin—urinary bladder cancer	0.000137	0.00121	CcSEcCtD
Amprenavir—Abdominal pain—Epirubicin—urinary bladder cancer	0.000136	0.0012	CcSEcCtD
Amprenavir—Asthenia—Methotrexate—urinary bladder cancer	0.000132	0.00116	CcSEcCtD
Amprenavir—Gastrointestinal pain—Doxorubicin—urinary bladder cancer	0.00013	0.00115	CcSEcCtD
Amprenavir—Pruritus—Methotrexate—urinary bladder cancer	0.00013	0.00115	CcSEcCtD
Amprenavir—Abdominal pain—Doxorubicin—urinary bladder cancer	0.000126	0.00111	CcSEcCtD
Amprenavir—Diarrhoea—Methotrexate—urinary bladder cancer	0.000126	0.00111	CcSEcCtD
Amprenavir—Asthenia—Epirubicin—urinary bladder cancer	0.000124	0.00109	CcSEcCtD
Amprenavir—Pruritus—Epirubicin—urinary bladder cancer	0.000122	0.00107	CcSEcCtD
Amprenavir—Diarrhoea—Epirubicin—urinary bladder cancer	0.000118	0.00104	CcSEcCtD
Amprenavir—Vomiting—Methotrexate—urinary bladder cancer	0.000117	0.00103	CcSEcCtD
Amprenavir—Rash—Methotrexate—urinary bladder cancer	0.000116	0.00102	CcSEcCtD
Amprenavir—Dermatitis—Methotrexate—urinary bladder cancer	0.000116	0.00102	CcSEcCtD
Amprenavir—Headache—Methotrexate—urinary bladder cancer	0.000115	0.00102	CcSEcCtD
Amprenavir—Asthenia—Doxorubicin—urinary bladder cancer	0.000114	0.00101	CcSEcCtD
Amprenavir—Pruritus—Doxorubicin—urinary bladder cancer	0.000113	0.000995	CcSEcCtD
Amprenavir—Vomiting—Epirubicin—urinary bladder cancer	0.000109	0.000966	CcSEcCtD
Amprenavir—Nausea—Methotrexate—urinary bladder cancer	0.000109	0.000964	CcSEcCtD
Amprenavir—Diarrhoea—Doxorubicin—urinary bladder cancer	0.000109	0.000962	CcSEcCtD
Amprenavir—Rash—Epirubicin—urinary bladder cancer	0.000109	0.000958	CcSEcCtD
Amprenavir—Dermatitis—Epirubicin—urinary bladder cancer	0.000108	0.000957	CcSEcCtD
Amprenavir—Headache—Epirubicin—urinary bladder cancer	0.000108	0.000952	CcSEcCtD
Amprenavir—Nausea—Epirubicin—urinary bladder cancer	0.000102	0.000902	CcSEcCtD
Amprenavir—Vomiting—Doxorubicin—urinary bladder cancer	0.000101	0.000894	CcSEcCtD
Amprenavir—Rash—Doxorubicin—urinary bladder cancer	0.0001	0.000886	CcSEcCtD
Amprenavir—Dermatitis—Doxorubicin—urinary bladder cancer	0.0001	0.000886	CcSEcCtD
Amprenavir—Headache—Doxorubicin—urinary bladder cancer	9.98e-05	0.000881	CcSEcCtD
Amprenavir—Nausea—Doxorubicin—urinary bladder cancer	9.46e-05	0.000835	CcSEcCtD
Amprenavir—ABCC1—Metabolism—ENO2—urinary bladder cancer	4.03e-05	0.000427	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	4.02e-05	0.000426	CbGpPWpGaD
Amprenavir—ABCC1—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	4.01e-05	0.000425	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—UGT2B7—urinary bladder cancer	4e-05	0.000424	CbGpPWpGaD
Amprenavir—ABCC1—Metabolism—GSTT1—urinary bladder cancer	3.91e-05	0.000414	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—SLC19A1—urinary bladder cancer	3.91e-05	0.000414	CbGpPWpGaD
Amprenavir—ABCC1—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	3.85e-05	0.000408	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—PRSS3—urinary bladder cancer	3.81e-05	0.000404	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—UGT2B7—urinary bladder cancer	3.77e-05	0.0004	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—UGT2B7—urinary bladder cancer	3.74e-05	0.000396	CbGpPWpGaD
Amprenavir—ABCB1—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	3.72e-05	0.000394	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—CYP4B1—urinary bladder cancer	3.69e-05	0.000391	CbGpPWpGaD
Amprenavir—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—urinary bladder cancer	3.67e-05	0.000389	CbGpPWpGaD
Amprenavir—ABCC1—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	3.66e-05	0.000388	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—CYP4B1—urinary bladder cancer	3.6e-05	0.000382	CbGpPWpGaD
Amprenavir—CYP2B6—Metabolism—TYMP—urinary bladder cancer	3.59e-05	0.000381	CbGpPWpGaD
Amprenavir—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—urinary bladder cancer	3.59e-05	0.000381	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—TYMP—urinary bladder cancer	3.51e-05	0.000373	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—SLC19A1—urinary bladder cancer	3.49e-05	0.00037	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—SLC19A1—urinary bladder cancer	3.4e-05	0.000361	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—PRSS3—urinary bladder cancer	3.4e-05	0.00036	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—CYP4B1—urinary bladder cancer	3.4e-05	0.00036	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—CYP4B1—urinary bladder cancer	3.37e-05	0.000357	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—PRSS3—urinary bladder cancer	3.32e-05	0.000352	CbGpPWpGaD
Amprenavir—CYP2B6—Metabolism—NAT2—urinary bladder cancer	3.25e-05	0.000345	CbGpPWpGaD
Amprenavir—ABCC1—Metabolism—NQO1—urinary bladder cancer	3.25e-05	0.000344	CbGpPWpGaD
Amprenavir—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—urinary bladder cancer	3.24e-05	0.000344	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—SLC19A1—urinary bladder cancer	3.21e-05	0.00034	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—SLC19A1—urinary bladder cancer	3.18e-05	0.000337	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—NAT2—urinary bladder cancer	3.18e-05	0.000337	CbGpPWpGaD
Amprenavir—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	3.15e-05	0.000334	CbGpPWpGaD
Amprenavir—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—urinary bladder cancer	3.14e-05	0.000333	CbGpPWpGaD
Amprenavir—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—urinary bladder cancer	3.13e-05	0.000332	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—PRSS3—urinary bladder cancer	3.12e-05	0.000331	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—PRSS3—urinary bladder cancer	3.1e-05	0.000328	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	3.05e-05	0.000324	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—TYMP—urinary bladder cancer	3.04e-05	0.000323	CbGpPWpGaD
Amprenavir—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—urinary bladder cancer	2.99e-05	0.000317	CbGpPWpGaD
Amprenavir—ABCC1—Disease—NCOR1—urinary bladder cancer	2.97e-05	0.000315	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	2.92e-05	0.00031	CbGpPWpGaD
Amprenavir—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—urinary bladder cancer	2.9e-05	0.000308	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—GSTZ1—urinary bladder cancer	2.84e-05	0.000302	CbGpPWpGaD
Amprenavir—CYP2B6—Metabolism—RRM2—urinary bladder cancer	2.81e-05	0.000298	CbGpPWpGaD
Amprenavir—ABCC1—Disease—ERCC2—urinary bladder cancer	2.79e-05	0.000296	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—NAT2—urinary bladder cancer	2.75e-05	0.000292	CbGpPWpGaD
Amprenavir—ABCC1—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	2.75e-05	0.000291	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—RRM2—urinary bladder cancer	2.74e-05	0.000291	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	2.72e-05	0.000289	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—TYMP—urinary bladder cancer	2.72e-05	0.000288	CbGpPWpGaD
Amprenavir—ABCC1—Metabolism—GSTP1—urinary bladder cancer	2.71e-05	0.000287	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—NAT1—urinary bladder cancer	2.7e-05	0.000286	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—GSTO2—urinary bladder cancer	2.7e-05	0.000286	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—TYMP—urinary bladder cancer	2.65e-05	0.000281	CbGpPWpGaD
Amprenavir—ABCC1—Disease—MTHFR—urinary bladder cancer	2.63e-05	0.000278	CbGpPWpGaD
Amprenavir—ABCC1—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	2.62e-05	0.000278	CbGpPWpGaD
Amprenavir—ABCC1—Disease—TERT—urinary bladder cancer	2.62e-05	0.000278	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	2.61e-05	0.000277	CbGpPWpGaD
Amprenavir—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—urinary bladder cancer	2.6e-05	0.000276	CbGpPWpGaD
Amprenavir—CYP2B6—Metabolism—HPGDS—urinary bladder cancer	2.6e-05	0.000276	CbGpPWpGaD
Amprenavir—CYP2B6—Metabolism—ENO2—urinary bladder cancer	2.6e-05	0.000276	CbGpPWpGaD
Amprenavir—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—urinary bladder cancer	2.54e-05	0.00027	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—HPGDS—urinary bladder cancer	2.54e-05	0.000269	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—ENO2—urinary bladder cancer	2.54e-05	0.000269	CbGpPWpGaD
Amprenavir—CYP2B6—Metabolism—GSTT1—urinary bladder cancer	2.52e-05	0.000267	CbGpPWpGaD
Amprenavir—ABCC1—Metabolism—TYMS—urinary bladder cancer	2.52e-05	0.000267	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—TYMP—urinary bladder cancer	2.5e-05	0.000265	CbGpPWpGaD
Amprenavir—ABCC1—Metabolism—NCOR1—urinary bladder cancer	2.49e-05	0.000264	CbGpPWpGaD
Amprenavir—ABCC1—Metabolism—GSTM1—urinary bladder cancer	2.49e-05	0.000264	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	2.48e-05	0.000263	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—TYMP—urinary bladder cancer	2.48e-05	0.000263	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—UGT2B7—urinary bladder cancer	2.47e-05	0.000261	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—GSTT1—urinary bladder cancer	2.46e-05	0.000261	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—NAT2—urinary bladder cancer	2.46e-05	0.00026	CbGpPWpGaD
Amprenavir—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—urinary bladder cancer	2.42e-05	0.000257	CbGpPWpGaD
Amprenavir—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—urinary bladder cancer	2.4e-05	0.000255	CbGpPWpGaD
Amprenavir—ABCC1—Disease—FGFR3—urinary bladder cancer	2.4e-05	0.000255	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—NAT2—urinary bladder cancer	2.4e-05	0.000254	CbGpPWpGaD
Amprenavir—ABCC1—Metabolism—GPX1—urinary bladder cancer	2.38e-05	0.000253	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	2.38e-05	0.000252	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—RRM2—urinary bladder cancer	2.38e-05	0.000252	CbGpPWpGaD
Amprenavir—ABCC1—Metabolism—ERCC2—urinary bladder cancer	2.34e-05	0.000248	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—NAT2—urinary bladder cancer	2.26e-05	0.00024	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—NAT2—urinary bladder cancer	2.24e-05	0.000237	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—CYP4B1—urinary bladder cancer	2.22e-05	0.000235	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—HPGDS—urinary bladder cancer	2.2e-05	0.000233	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—ENO2—urinary bladder cancer	2.2e-05	0.000233	CbGpPWpGaD
Amprenavir—ABCC1—Metabolism—MTHFR—urinary bladder cancer	2.2e-05	0.000233	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	2.19e-05	0.000232	CbGpPWpGaD
Amprenavir—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—urinary bladder cancer	2.14e-05	0.000227	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—GSTT1—urinary bladder cancer	2.13e-05	0.000226	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—RRM2—urinary bladder cancer	2.12e-05	0.000225	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	2.1e-05	0.000223	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—SLC19A1—urinary bladder cancer	2.1e-05	0.000222	CbGpPWpGaD
Amprenavir—CYP2B6—Metabolism—NQO1—urinary bladder cancer	2.09e-05	0.000222	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—RRM2—urinary bladder cancer	2.07e-05	0.000219	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—NQO1—urinary bladder cancer	2.05e-05	0.000217	CbGpPWpGaD
Amprenavir—ABCC1—Disease—CREBBP—urinary bladder cancer	2.05e-05	0.000217	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—PRSS3—urinary bladder cancer	2.04e-05	0.000217	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—ENO2—urinary bladder cancer	1.96e-05	0.000208	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—HPGDS—urinary bladder cancer	1.96e-05	0.000208	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	1.95e-05	0.000207	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—RRM2—urinary bladder cancer	1.95e-05	0.000207	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—RRM2—urinary bladder cancer	1.93e-05	0.000205	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—ENO2—urinary bladder cancer	1.92e-05	0.000203	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—HPGDS—urinary bladder cancer	1.92e-05	0.000203	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—GSTT1—urinary bladder cancer	1.9e-05	0.000202	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	1.88e-05	0.000199	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—GSTT1—urinary bladder cancer	1.86e-05	0.000197	CbGpPWpGaD
Amprenavir—ABCC1—Disease—RHOA—urinary bladder cancer	1.85e-05	0.000196	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—ENO2—urinary bladder cancer	1.81e-05	0.000192	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—HPGDS—urinary bladder cancer	1.81e-05	0.000192	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—ENO2—urinary bladder cancer	1.79e-05	0.00019	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—HPGDS—urinary bladder cancer	1.79e-05	0.00019	CbGpPWpGaD
Amprenavir—ABCC1—Metabolism—PPARG—urinary bladder cancer	1.78e-05	0.000189	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	1.78e-05	0.000189	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—NQO1—urinary bladder cancer	1.77e-05	0.000188	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—GSTT1—urinary bladder cancer	1.75e-05	0.000186	CbGpPWpGaD
Amprenavir—CYP2B6—Metabolism—GSTP1—urinary bladder cancer	1.75e-05	0.000185	CbGpPWpGaD
Amprenavir—ABCB1—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	1.74e-05	0.000185	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—GSTT1—urinary bladder cancer	1.74e-05	0.000184	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	1.72e-05	0.000182	CbGpPWpGaD
Amprenavir—ABCC1—Metabolism—CREBBP—urinary bladder cancer	1.71e-05	0.000182	CbGpPWpGaD
Amprenavir—ABCC1—Disease—ERBB2—urinary bladder cancer	1.71e-05	0.000182	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	1.71e-05	0.000181	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—GSTP1—urinary bladder cancer	1.71e-05	0.000181	CbGpPWpGaD
Amprenavir—ABCC1—Disease—PTGS2—urinary bladder cancer	1.68e-05	0.000178	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—TYMP—urinary bladder cancer	1.63e-05	0.000173	CbGpPWpGaD
Amprenavir—CYP2B6—Metabolism—TYMS—urinary bladder cancer	1.62e-05	0.000172	CbGpPWpGaD
Amprenavir—CYP2B6—Metabolism—GSTM1—urinary bladder cancer	1.61e-05	0.00017	CbGpPWpGaD
Amprenavir—CYP2B6—Metabolism—NCOR1—urinary bladder cancer	1.61e-05	0.00017	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—TYMS—urinary bladder cancer	1.59e-05	0.000168	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—NQO1—urinary bladder cancer	1.58e-05	0.000168	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—GSTM1—urinary bladder cancer	1.57e-05	0.000166	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—NCOR1—urinary bladder cancer	1.57e-05	0.000166	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—NQO1—urinary bladder cancer	1.54e-05	0.000164	CbGpPWpGaD
Amprenavir—CYP2B6—Metabolism—GPX1—urinary bladder cancer	1.54e-05	0.000163	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	1.54e-05	0.000163	CbGpPWpGaD
Amprenavir—CYP2B6—Metabolism—ERCC2—urinary bladder cancer	1.51e-05	0.00016	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—GPX1—urinary bladder cancer	1.5e-05	0.000159	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	1.5e-05	0.000159	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—GSTP1—urinary bladder cancer	1.48e-05	0.000157	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—NAT2—urinary bladder cancer	1.48e-05	0.000157	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—ERCC2—urinary bladder cancer	1.48e-05	0.000156	CbGpPWpGaD
Amprenavir—ABCC1—Disease—CDKN1A—urinary bladder cancer	1.46e-05	0.000155	CbGpPWpGaD
Amprenavir—ABCC1—Disease—PTEN—urinary bladder cancer	1.46e-05	0.000155	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—NQO1—urinary bladder cancer	1.46e-05	0.000154	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—NQO1—urinary bladder cancer	1.44e-05	0.000153	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	1.43e-05	0.000152	CbGpPWpGaD
Amprenavir—CYP2B6—Metabolism—MTHFR—urinary bladder cancer	1.42e-05	0.00015	CbGpPWpGaD
Amprenavir—ABCC1—Metabolism—PTGS2—urinary bladder cancer	1.4e-05	0.000149	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	1.4e-05	0.000148	CbGpPWpGaD
Amprenavir—ABCC1—Disease—EP300—urinary bladder cancer	1.39e-05	0.000148	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—MTHFR—urinary bladder cancer	1.39e-05	0.000147	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—TYMS—urinary bladder cancer	1.37e-05	0.000146	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—NCOR1—urinary bladder cancer	1.36e-05	0.000144	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—GSTM1—urinary bladder cancer	1.36e-05	0.000144	CbGpPWpGaD
Amprenavir—ABCC1—Disease—SRC—urinary bladder cancer	1.36e-05	0.000144	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	1.34e-05	0.000142	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—GSTP1—urinary bladder cancer	1.32e-05	0.00014	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—GPX1—urinary bladder cancer	1.3e-05	0.000138	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—GSTP1—urinary bladder cancer	1.29e-05	0.000137	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—ERCC2—urinary bladder cancer	1.28e-05	0.000135	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	1.28e-05	0.000135	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—RRM2—urinary bladder cancer	1.28e-05	0.000135	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—TYMS—urinary bladder cancer	1.23e-05	0.00013	CbGpPWpGaD
Amprenavir—ABCC1—Metabolism—PTEN—urinary bladder cancer	1.22e-05	0.00013	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	1.22e-05	0.000129	CbGpPWpGaD
Amprenavir—ABCC1—Disease—MYC—urinary bladder cancer	1.21e-05	0.000129	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—GSTP1—urinary bladder cancer	1.21e-05	0.000129	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—GSTM1—urinary bladder cancer	1.21e-05	0.000129	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—NCOR1—urinary bladder cancer	1.21e-05	0.000129	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—GSTP1—urinary bladder cancer	1.2e-05	0.000128	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—MTHFR—urinary bladder cancer	1.2e-05	0.000127	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—TYMS—urinary bladder cancer	1.2e-05	0.000127	CbGpPWpGaD
Amprenavir—ABCC1—Disease—EGFR—urinary bladder cancer	1.19e-05	0.000126	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—NCOR1—urinary bladder cancer	1.18e-05	0.000126	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—GSTM1—urinary bladder cancer	1.18e-05	0.000126	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—HPGDS—urinary bladder cancer	1.18e-05	0.000125	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—ENO2—urinary bladder cancer	1.18e-05	0.000125	CbGpPWpGaD
Amprenavir—ABCC1—Metabolism—EP300—urinary bladder cancer	1.17e-05	0.000124	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	1.16e-05	0.000123	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—GPX1—urinary bladder cancer	1.16e-05	0.000123	CbGpPWpGaD
Amprenavir—CYP2B6—Metabolism—PPARG—urinary bladder cancer	1.15e-05	0.000122	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—GSTT1—urinary bladder cancer	1.15e-05	0.000121	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—ERCC2—urinary bladder cancer	1.14e-05	0.000121	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—GPX1—urinary bladder cancer	1.13e-05	0.00012	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—TYMS—urinary bladder cancer	1.13e-05	0.00012	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—PPARG—urinary bladder cancer	1.12e-05	0.000119	CbGpPWpGaD
Amprenavir—ABCC1—Disease—KRAS—urinary bladder cancer	1.12e-05	0.000119	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—TYMS—urinary bladder cancer	1.12e-05	0.000119	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—NCOR1—urinary bladder cancer	1.12e-05	0.000118	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—GSTM1—urinary bladder cancer	1.12e-05	0.000118	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—ERCC2—urinary bladder cancer	1.11e-05	0.000118	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—GSTM1—urinary bladder cancer	1.11e-05	0.000117	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—NCOR1—urinary bladder cancer	1.11e-05	0.000117	CbGpPWpGaD
Amprenavir—CYP2B6—Metabolism—CREBBP—urinary bladder cancer	1.11e-05	0.000117	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—CREBBP—urinary bladder cancer	1.08e-05	0.000115	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—MTHFR—urinary bladder cancer	1.07e-05	0.000114	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—GPX1—urinary bladder cancer	1.07e-05	0.000113	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—GPX1—urinary bladder cancer	1.06e-05	0.000112	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—ERCC2—urinary bladder cancer	1.05e-05	0.000111	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—MTHFR—urinary bladder cancer	1.05e-05	0.000111	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—ERCC2—urinary bladder cancer	1.04e-05	0.00011	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—MTHFR—urinary bladder cancer	9.86e-06	0.000105	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—MTHFR—urinary bladder cancer	9.78e-06	0.000104	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—PPARG—urinary bladder cancer	9.74e-06	0.000103	CbGpPWpGaD
Amprenavir—ABCC1—Disease—HRAS—urinary bladder cancer	9.54e-06	0.000101	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—NQO1—urinary bladder cancer	9.52e-06	0.000101	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—CREBBP—urinary bladder cancer	9.36e-06	9.92e-05	CbGpPWpGaD
Amprenavir—CYP2B6—Metabolism—PTGS2—urinary bladder cancer	9.05e-06	9.6e-05	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—PTGS2—urinary bladder cancer	8.85e-06	9.38e-05	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—PPARG—urinary bladder cancer	8.69e-06	9.22e-05	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—PPARG—urinary bladder cancer	8.49e-06	9e-05	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—CREBBP—urinary bladder cancer	8.35e-06	8.86e-05	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—CREBBP—urinary bladder cancer	8.15e-06	8.64e-05	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—PPARG—urinary bladder cancer	8e-06	8.48e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—GSTP1—urinary bladder cancer	7.94e-06	8.42e-05	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—PPARG—urinary bladder cancer	7.93e-06	8.41e-05	CbGpPWpGaD
Amprenavir—CYP2B6—Metabolism—PTEN—urinary bladder cancer	7.89e-06	8.37e-05	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—PTEN—urinary bladder cancer	7.71e-06	8.18e-05	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—CREBBP—urinary bladder cancer	7.68e-06	8.15e-05	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—PTGS2—urinary bladder cancer	7.66e-06	8.12e-05	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—CREBBP—urinary bladder cancer	7.62e-06	8.07e-05	CbGpPWpGaD
Amprenavir—CYP2B6—Metabolism—EP300—urinary bladder cancer	7.53e-06	7.98e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—TYMS—urinary bladder cancer	7.38e-06	7.83e-05	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—EP300—urinary bladder cancer	7.36e-06	7.8e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—GSTM1—urinary bladder cancer	7.3e-06	7.74e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—NCOR1—urinary bladder cancer	7.3e-06	7.74e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—GPX1—urinary bladder cancer	6.99e-06	7.41e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—ERCC2—urinary bladder cancer	6.86e-06	7.27e-05	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—PTGS2—urinary bladder cancer	6.84e-06	7.25e-05	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—PTEN—urinary bladder cancer	6.68e-06	7.09e-05	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—PTGS2—urinary bladder cancer	6.68e-06	7.08e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—MTHFR—urinary bladder cancer	6.45e-06	6.84e-05	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—EP300—urinary bladder cancer	6.37e-06	6.76e-05	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—PTGS2—urinary bladder cancer	6.29e-06	6.67e-05	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—PTGS2—urinary bladder cancer	6.24e-06	6.61e-05	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—PTEN—urinary bladder cancer	5.96e-06	6.32e-05	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—PTEN—urinary bladder cancer	5.82e-06	6.17e-05	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—EP300—urinary bladder cancer	5.69e-06	6.03e-05	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—EP300—urinary bladder cancer	5.55e-06	5.89e-05	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—PTEN—urinary bladder cancer	5.49e-06	5.82e-05	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—PTEN—urinary bladder cancer	5.44e-06	5.77e-05	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—EP300—urinary bladder cancer	5.23e-06	5.55e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—PPARG—urinary bladder cancer	5.23e-06	5.54e-05	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—EP300—urinary bladder cancer	5.19e-06	5.5e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—CREBBP—urinary bladder cancer	5.02e-06	5.33e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—PTGS2—urinary bladder cancer	4.11e-06	4.36e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—PTEN—urinary bladder cancer	3.59e-06	3.8e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—EP300—urinary bladder cancer	3.42e-06	3.63e-05	CbGpPWpGaD
